BR112015002268A2 - produção de vírus influenza infecciosos - Google Patents
produção de vírus influenza infecciososInfo
- Publication number
- BR112015002268A2 BR112015002268A2 BR112015002268A BR112015002268A BR112015002268A2 BR 112015002268 A2 BR112015002268 A2 BR 112015002268A2 BR 112015002268 A BR112015002268 A BR 112015002268A BR 112015002268 A BR112015002268 A BR 112015002268A BR 112015002268 A2 BR112015002268 A2 BR 112015002268A2
- Authority
- BR
- Brazil
- Prior art keywords
- infectious influenza
- production
- influenza viruses
- infectious
- viruses
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 5
- 230000002458 infectious effect Effects 0.000 title abstract 5
- 241000712461 unidentified influenza virus Species 0.000 title abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 238000005215 recombination Methods 0.000 abstract 2
- 230000006798 recombination Effects 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/00051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/00051—Methods of production or purification of viral material
- C12N2760/00052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C12N2760/16164—Methods of inactivation or attenuation by serial passage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16261—Methods of inactivation or attenuation
- C12N2760/16264—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305968 | 2012-08-03 | ||
| PCT/EP2013/065920 WO2014019990A1 (en) | 2012-08-03 | 2013-07-29 | Production of infectious influenza viruses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015002268A2 true BR112015002268A2 (pt) | 2017-11-07 |
Family
ID=48900986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015002268A BR112015002268A2 (pt) | 2012-08-03 | 2013-07-29 | produção de vírus influenza infecciosos |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9982240B2 (enExample) |
| EP (1) | EP2880154B1 (enExample) |
| JP (1) | JP6335167B2 (enExample) |
| KR (1) | KR20150038374A (enExample) |
| CN (1) | CN104704112A (enExample) |
| AU (1) | AU2013298632B2 (enExample) |
| BR (1) | BR112015002268A2 (enExample) |
| CA (1) | CA2880409A1 (enExample) |
| MX (1) | MX360120B (enExample) |
| SG (1) | SG11201500508XA (enExample) |
| WO (1) | WO2014019990A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1222882A1 (zh) * | 2013-06-06 | 2017-07-14 | Novartis Ag | 流感病毒重配 |
| CN104232594B (zh) * | 2014-09-11 | 2017-05-31 | 中国农业科学院哈尔滨兽医研究所 | 重组类禽型h1n1流感病毒灭活疫苗株(js40/pr8)及其制备方法和应用 |
| CN105754997B (zh) * | 2016-03-30 | 2019-02-26 | 华中农业大学 | 狂犬病毒drv-ah08株的先导rna及其在制备预防与治疗狂犬病毒的药品中的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT833934E (pt) | 1995-06-15 | 2005-02-28 | Crucell Holland Bv | Sistemas de empacotamento para adenovivrus recombinente humano destinados a terapia genetica |
| TW389999B (en) | 1995-11-21 | 2000-05-11 | Toshiba Corp | Substrate having shallow trench isolation and method of manufacturing the same |
| US6544785B1 (en) | 1998-09-14 | 2003-04-08 | Mount Sinai School Of Medicine Of New York University | Helper-free rescue of recombinant negative strand RNA viruses |
| US8715940B2 (en) | 1999-04-06 | 2014-05-06 | Wisconsin Alumni Research Foundation | Method of making recombinant influenza virus |
| GB9916794D0 (en) * | 1999-07-16 | 1999-09-22 | Isis Innovation | In vitro virus reconstitution |
| GB9923176D0 (en) | 1999-09-30 | 1999-12-01 | Smithkline Beecham Biolog | Novel composition |
| AU2001259211B2 (en) | 2000-04-28 | 2006-07-13 | St. Jude Children's Research Hospital | DNA transfection system for the generation of infectious influenza virus |
| DE50201240D1 (de) | 2001-04-23 | 2004-11-11 | Amaxa Gmbh | Pufferlössung für die elektroporation und verfahren umfassend die verwendung derselben |
| US20050158342A1 (en) | 2003-12-23 | 2005-07-21 | Medimmune, Inc. | Multi plasmid system for the production of influenza virus |
| EP1722815A1 (en) * | 2004-03-09 | 2006-11-22 | Chiron Corporation | Influenza virus vaccines |
| DE502005002350D1 (de) | 2005-07-07 | 2008-02-07 | Amaxa Ag | Verfahren zur Behandlung geringer Volumina mit elektrischem Strom |
| US20070111309A1 (en) | 2005-10-04 | 2007-05-17 | Daelli Marcelo G | Vero cell line adapted to grow in suspension |
| CN100571775C (zh) * | 2006-11-09 | 2009-12-23 | 中国农业科学院哈尔滨兽医研究所 | 禽流感病毒标记疫苗及其制备方法和应用 |
| US8163523B2 (en) * | 2008-06-11 | 2012-04-24 | Flugen, Inc. | Cell-based systems for producing influenza vaccines |
| DK2307538T3 (da) | 2008-07-15 | 2016-01-18 | Crucell Holland Bv | Skalérbar fremgangsmåde til dyrkning af per.c6-celler og fremstilling af produkter derfra |
-
2013
- 2013-07-29 SG SG11201500508XA patent/SG11201500508XA/en unknown
- 2013-07-29 US US14/419,235 patent/US9982240B2/en active Active
- 2013-07-29 CN CN201380051942.6A patent/CN104704112A/zh active Pending
- 2013-07-29 JP JP2015524755A patent/JP6335167B2/ja not_active Expired - Fee Related
- 2013-07-29 EP EP13742451.1A patent/EP2880154B1/en active Active
- 2013-07-29 KR KR1020157004966A patent/KR20150038374A/ko not_active Withdrawn
- 2013-07-29 CA CA2880409A patent/CA2880409A1/en not_active Abandoned
- 2013-07-29 WO PCT/EP2013/065920 patent/WO2014019990A1/en not_active Ceased
- 2013-07-29 MX MX2015001499A patent/MX360120B/es active IP Right Grant
- 2013-07-29 AU AU2013298632A patent/AU2013298632B2/en not_active Ceased
- 2013-07-29 BR BR112015002268A patent/BR112015002268A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20150191703A1 (en) | 2015-07-09 |
| AU2013298632A1 (en) | 2015-02-26 |
| EP2880154A1 (en) | 2015-06-10 |
| AU2013298632B2 (en) | 2018-11-01 |
| CN104704112A (zh) | 2015-06-10 |
| JP6335167B2 (ja) | 2018-05-30 |
| WO2014019990A1 (en) | 2014-02-06 |
| SG11201500508XA (en) | 2015-02-27 |
| CA2880409A1 (en) | 2014-02-06 |
| KR20150038374A (ko) | 2015-04-08 |
| US9982240B2 (en) | 2018-05-29 |
| MX360120B (es) | 2018-10-23 |
| JP2015530875A (ja) | 2015-10-29 |
| MX2015001499A (es) | 2015-08-20 |
| EP2880154B1 (en) | 2019-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123570T1 (el) | Τροποποιητες πυρηνικης πρωτεϊνης ηπατιτιδας β | |
| CY1123208T1 (el) | Κυκλικα παραγωγα εστερων βορονικου οξεος, μεθοδος για την παρασκευη και θεραπευτικες χρησεις αυτων | |
| CY1119056T1 (el) | Παραγωγα 2',4',-διφθορο-2'-μεθυλ υποκατεστημενου νουκλεοσιδιου ως αναστολεις αντιγραφης hcv rna | |
| AR089578A1 (es) | Composiciones, metodos para tratar el virus de la hepatitis c y proceso de preparacion | |
| MX2019003525A (es) | Moduladores alostericos de proteina nucleo de hepatitis b. | |
| BR112016020688A2 (pt) | Composições úteis no tratamento da deficiência da ornitina transcarbamilase (otc) | |
| JO3204B1 (ar) | 4- أريل-n- فنيل-5،3،1- ترايازين-2- أمينات محتوية على مجموعة سلفوكسيمين | |
| PE20150862A1 (es) | Inhibidores macrociclicos de virus flaviviridae | |
| CR20180094A (es) | Proceso para la producción de cannabidol y delta-9-tetrahidrocannabinol | |
| BR112014003919A2 (pt) | métodos e meios para modificar um genoma de planta | |
| CO6341569A2 (es) | Vacuna de vesicula de membrana externa nativa multivalente del meningococo, metodo para su fabricacion y uso. | |
| MX2012008221A (es) | Inhibidores de virus flaviviridae. | |
| ECSP12012067A (es) | Inhibidores del virus de la hepatitis c | |
| MX2012008211A (es) | Inhibidores de virus flaviviridae. | |
| PH12013502442A1 (en) | Inactivated dengue virus vaccine | |
| MX2016003419A (es) | Metodos y composiciones para sindrome respiratorio coronavirus de oriente medio (mers-cov) inmunogenico. | |
| BR112015031913A2 (pt) | processo para a fabricação de amino-benzoxazinonas 4-propargilatadas e sua utilização | |
| UY33897A (es) | Inhibidores del virus de la hepatitis c | |
| BR112015005416A2 (pt) | produção de ácidos orgânicos por meio de fermentação em baixo ph | |
| ECSP13012438A (es) | Proceso para preparar compuestos antivirales | |
| AR081656A1 (es) | Producto que comprende stevia | |
| PH12013502177A1 (en) | Hepatitis c virus inhibitors | |
| MX360452B (es) | Inhibidores del virus de la hepatitis c. | |
| UA116697C2 (uk) | Композиція для запобігання зараженню видами роду mycoplasma | |
| BR112014015582A8 (pt) | compostos antivirais |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B06I | Technical and formal requirements: publication cancelled |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
| B07E | Notice of approval relating to section 229 industrial property law | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |